1832 Asset Management’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

1832 Asset Management’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-335	Closed	–	–	739
2015 Q3	$0	Hold	335	–	–	﹤0.01%	733
2015 Q2	$0	Hold	335	–	–	﹤0.01%	759
2015 Q1	$0	Sell	335 -715	-68%	-$459	﹤0.01%	727
2014 Q4	$1K	Sell	1,050 -1,446,900	-100%	-$875K	﹤0.01%	605
2014 Q3	$828K	Sell	1,447,950 -1,378,300	-49%	-$1.75M	﹤0.01%	445
2014 Q2	$3.63M	Hold	2,826,250	–	–	0.01%	366
2014 Q1	$4.91M	Buy	2,826,250 +121,350	+4%	+$205K	0.02%	351
2013 Q4	$4.23M	Buy	2,704,900 +20,900	+0.8%	+$47.1K	0.02%	316
2013 Q3	$6.51M	Buy	2,684,000 +212,700	+9%	+$589K	0.03%	246
2013 Q2	$7.1M	Buy	+2,471,300	New	+$6.84M	0.03%	262

Other funds holding ONCY

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

KWMG

King Wealth Management Group Naples, Florida $914M AUM 24.3% 1-Year Est. Return

Credential Securities Vancouver $440M AUM 9.75% 1-Year Est. Return

1832 Asset Management's ONCY Position: Q4 2015 in Review

1832 Asset Management sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2015, closing a stake of 335 shares.

1832 Asset Management first reported a position in ONCY in Q2 2013 and held it in 10 quarters. The position peaked at $7.1M in Q2 2013. 7 funds tracked by Wall St. Rank hold ONCY as of Q4 2015.

1832 Asset Management reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2015 after selling out during the quarter.
1832 Asset Management sold 335 ONCOLYTICS BIOTECH INC shares in Q4 2015.
1832 Asset Management first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 10 quarters.
1832 Asset Management's ONCOLYTICS BIOTECH INC position peaked at $7.1M in Q2 2013.
7 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2015.

Based on 1832 Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.